Health Care & Life Sciences » Biotechnology | RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.68
Market Cap
$3.29 M
Shares Outstanding
3.87 M
Public Float
1.67 M

Profile

Address
126 Valley Road
Glen Rock New Jersey 07452
United States
Employees -
Website http://www.respirerx.com
Updated 07/08/2019
RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. It focuses on clinical development in the area of respiratory disorders, particularly sleep apneas and respiratory depression produced by drugs and neural damage, which provides the opportunities for development and commercialization of its compounds. The company was founded by Carl W.

Financials

View All

Arnold S. Lippa
Executive Chairman & Chief Scientific Officer
James S. J. Manuso
Vice Chairman, President & Chief Executive Officer